← Back to Search

Behavioural Intervention

PREVAIL Model of Care for Rheumatoid Arthritis

N/A

Waitlist Available

Led By Louise Thoma, DPT, PhD

Research Sponsored by University of North Carolina, Chapel Hill

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Clinician diagnosis of RA as defined by International Classification of Diseases 10 (ICD-10) code

Be older than 18 years old

Must not have

Significant cognitive impairment

Under the age of 18

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline assessments (including the daps tool) provided 1 week before routine visit, routine visit with rheumatology clinician, and 3-month follow-up assessments

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if a new method of integrating rehabilitation into routine care for adults with rheumatoid arthritis is practical. The method involves using a screening tool, providing recommendations for exercise and rehabilitation to

Who is the study for?

This trial is for adults with rheumatoid arthritis. Participants should be scheduled for a routine visit with their rheumatology clinician and willing to follow the PREVAIL model of care, which includes using an online exercise resource. Details on specific inclusion or exclusion criteria are not provided.

What is being tested?

The PREVAIL model of care is being tested to see if it's a good way to add rehabilitation into regular treatment for rheumatoid arthritis patients. It involves screening with DAPS, advice on rehab and exercise from clinicians, and an online exercise program tailored for RA.

What are the potential side effects?

Since this trial focuses on a model of care involving assessment tools and recommendations rather than medication or invasive procedures, traditional side effects are not applicable. However, participants may experience discomfort or fatigue related to new exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with rheumatoid arthritis.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have significant memory or thinking problems.

Select...

I am under 18 years old.

Select...

I have not been diagnosed with rheumatoid arthritis.

Select...

I have severe hearing or vision problems.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ emr review and pre-screening (2 months prior to appointment) to enrollment (2 months to 1 week before routine visit)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~emr review and pre-screening (2 months prior to appointment) to enrollment (2 months to 1 week before routine visit)

This trial's timeline: 3 weeks for screening, Varies for treatment, and emr review and pre-screening (2 months prior to appointment) to enrollment (2 months to 1 week before routine visit) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Average score on the Acceptability of Intervention Measure (AIM)

Average score on the Feasibility of Intervention Measure (FIM)

Percentage of participants who access the exercise resource at least once during study duration

+1 more

Secondary study objectives

Percentage of participants that complete follow-up assessments

Percentage of recruitment pool who enroll in the study

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Intervention GroupExperimental Treatment1 Intervention

Participants will all receive a recommendation from their rheumatology provider based on their DAPS score. Recommendations will consist of an exercise resource and potentially a referral for a brief PT consultation call.

0 / 5Eligibility criteria met